Skip to content

PEPFAR: HIV prevention for injection drug users in Africa a growing issue

Rapid tests boost HIV diagnosis rate in US

Darunavir (TMC114) approved for use in treatment-experienced patients in US

Cigarette smoking may undermine benefits of potent antiretroviral therapy

Should anal Pap smears be introduced for people with HIV?

Diagnosis with pulmonary KS still `ominous` even in era of potent HIV therapy

Casting the first stone: the US Christian right’s war on the Global Fund

PEPFAR and Global Fund both highly effective, but is the funding sustainable?

Is PEPFAR competing or cooperating in treatment scale-up?